| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |